PT  - JOURNAL ARTICLE
AU  - Kuznar, Wayne
ED  - Genovese, Mark C.
TI  - Efficacy Maintained When Transitioning Directly from TNF Inhibitor to Tofacitinib in RA
DP  - 2013 Sep 01
TA  - MD Conference Express
PG  - 8--9
VI  - 13
IP  - 8
4099  - http://mdc.sagepub.com/content/13/8/8.short
4100  - http://mdc.sagepub.com/content/13/8/8.full
AB  - Patients with rheumatoid arthritis (RA) who transition directly from adalimumab to tofacitinib maintained a clinical response. This article presents results from the open-label extension Oral Rheumatoid Arthritis Phase 3 Trials Sequel study [ORAL; NCT00413699] of the randomized, double-blind, placebo-controlled ORAL Standard study in which the two treatments were compared in patients with active RA [NCT00853385].